EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Quantitative Whole‐Body Muscle MRI in Adults With Spinal Muscular Atrophy–A Sensitive Tool for Long‐Time Evaluation of Disease Progression

Alexander Mensch iD, Benjamin Troppa, Ilka Schneider, Caroline Deborah Stapf, Anna Katharina Koelsch, Thomas Kendzierski, David Strube, Sebastian Plutz, Max Obenauf, Karl-Stefan Delank, Torsten Kraya, Markus Otto and 2 more

European Journal of Neurology · 2026-03 · 33 (3)

DOI: 10.1111/ene.70579 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2026-03-23. Written by Alexander Mensch and 13 co-authors. Institution: Department of Neurology, University Medicine Halle, Halle (Saale), Saxony-Anhalt, Germany. Major MEDLINE topics: Magnetic Resonance Imaging, Muscular Atrophy, Spinal, Disease Progression, Muscle, Skeletal. 36 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Spinal muscular atrophy (SMA) is a neuromuscular disorder characterized by progressive muscle weakness due to SMN protein deficiency. While effective therapies exist, their impact on slowly progressive adult SMA patients remains unclear. Reliable biomarkers for monitoring disease progression and treatment response are urgently needed. This pilot study evaluated the utility of longitudinal quantitative muscle MRI (qMRI) to monitor disease progression in adult SMA patients treated with nusinersen over an extended period.

Methods

Nine adult patients with genetically confirmed 5q‐SMA underwent whole‐body muscle MRI and clinical assessment, including the Hammersmith Functional Motor Scale‐Expanded (HFMS‐EXP), Revised Upper Limb Module (RULM), and 6 min walk test (6MWT). Muscular fat fraction (mFF) was quantified in 20 muscles over a median follow‐up of 54 months.

Results

Baseline mFF correlated strongly with clinical measures (HFMS‐EXP: r = −0.90, p = 0.001; 6MWT: r = −0.96, p < 0.001), but not with age at onset or age at MRI. Over the observation period, a significant increase in mFF was detected (averaged annual increase of all studied muscles: 0.47%, p = 0.011), accentuated in the lower leg muscles. In contrast, clinical measures showed no consistent change. Consequently, no significant correlations were found between changes in mFF and clinical scores.

Conclusions

This study provides the longest reported longitudinal qMRI assessment in adult SMA patients treated with nusinersen, demonstrating that mFF progressively increases despite stable clinical scores. The results suggest that qMRI may be a sensitive and objective biomarker for detecting subtle disease progression in adult SMA, potentially surpassing clinical measures.

Subjects

MeSH terms (MEDLINE)

Magnetic Resonance ImagingMuscular Atrophy, SpinalDisease ProgressionMuscle, SkeletalWhole Body ImagingHumansAdultMaleFemalePilot ProjectsMiddle AgedOligonucleotidesYoung AdultLongitudinal Studies

Author keywords

SMAimaging biomarkermuscular fat fractionnusinersenqMRI

Substances

nusinersenOligonucleotides

Authors and institutions

  • Department of Neurology, University Medicine Halle, Halle (Saale), Saxony-Anhalt, Germany.
  • Heimer Institute for Muscle Research, Heimer Institute for Muscle Research, Bochum, North Rhine-Westphalia, Germany.
  • Department of Radiology, University Medicine Halle, Halle (Saale), Saxony-Anhalt, Germany.
  • Department of Neurology, St. Georg Hospital Leipzig, Leipzig, Saxony, Germany.
  • Department of Orthopedic and Trauma Surgery, University Medicine Halle, Halle (Saale), Saxony-Anhalt, Germany.
  • Department of Neurology, Alfried Krupp Krankenhaus Essen, Essen, North Rhine-Westphalia, Germany.

ORCID profiles: Alexander Mensch, Dietrich Stoevesandt, Steffen Naegel

Cite

APA

Mensch, A., Troppa, B., Schneider, I., Stapf, C. D., Koelsch, A. K., Kendzierski, T., Strube, D., Plutz, S., Obenauf, M., Delank, K. S., Kraya, T., Otto, M., Stoevesandt, D., & Naegel, S. (2026). Quantitative Whole‐Body Muscle MRI in Adults With Spinal Muscular Atrophy–A Sensitive Tool for Long‐Time Evaluation of Disease Progression. European Journal of Neurology, 33(3). https://doi.org/10.1111/ene.70579

Vancouver

Mensch A, Troppa B, Schneider I, Stapf CD, Koelsch AK, Kendzierski T, et al. Quantitative Whole‐Body Muscle MRI in Adults With Spinal Muscular Atrophy–A Sensitive Tool for Long‐Time Evaluation of Disease Progression. European Journal of Neurology. 2026;33(3). doi:10.1111/ene.70579

BibTeX
@article{Mensch2026,
  author = {Mensch, Alexander and Troppa, Benjamin and Schneider, Ilka and Stapf, Caroline Deborah and Koelsch, Anna Katharina and Kendzierski, Thomas and Strube, David and Plutz, Sebastian and Obenauf, Max and Delank, Karl-Stefan and Kraya, Torsten and Otto, Markus and Stoevesandt, Dietrich and Naegel, Steffen},
  title = {Quantitative Whole‐Body Muscle MRI in Adults With Spinal Muscular Atrophy–A Sensitive Tool for Long‐Time Evaluation of Disease Progression},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {3},
  doi = {10.1111/ene.70579}
}
Start for free →